The University of Illinois Center for Nanoscale Science and Technology (CNST) has been leading the way in facilitating research leading to the development of ultra-small, ultra-light, wirelessly-connected nano devices and materials for nanomedicine. Preliminary results from research conducted at the Micro and Nanotechnology Laboratory (MNTL) using some of the equipment purchased from AFOSR grant. The grant enabled University of Illinois to markedly transform the recently expanded MNTL from being primarily compound semiconductor and micro/nano electronics facility, to also being a state-of-the-art multidisciplinary bionanotechnology laboratory space. This has not only helped the laboratory in conducting cutting-edge research, but also has been used in training the next generation workforce in bionanotechnology addressing such issues as battlefield injuries, viruses, and cancer. It also has enabled the CNST and MNTL to leverage extra-mural funding. The florescent optical microscope (Olympus IX 81) was used to study cardiac cells cultured on substrates with varying stiffness. Equipment is being used for screening a small molecule compound library for drug molecules that have the capability for treating Parkinson's Disease.
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INTRODUCTION
The University of Illinois Center for Nanoscale Science and Technology (CNST) working with several laboratories including the Micro and Nanotechnology Laboratory had envisaged the important role nanotechnology will play in the area of bone and tissue engineering. Some of the applications, which were conceived of included:
• Artificial skin for tissue reconstruction, burn, and wound healing • Tissues and organ development using nanopatterned scaffolds • Impregnation of substances for surface healing
The CNST is leading the way in facilitating research leading to the development of ultrasmall, ultra-light, wirelessly-connected nano devices and materials for nanomedicine. This report discusses the research conducted at the Micro and Nanotechnology Laboratory (MNTL) using some of the equipment purchased from AFOSR grant. A list of equipment purchased from the AFOSR grant and equipment purchased from the College of Engineering, University of Illinois matching funds is provided in Appendix I. 
Leveraging the Grant
For Funding
The AFOSR equipment grant has enabled us to generate preliminary data and to highlight recent bionanomedical equipment to submit a series of proposals to various funding agencies. Similarly, research papers have been submitted to journals, and conference presentations have been made; projects leveraging the purchased equipment, and proposals submitted as of this report are provided in Appendices II-V.. • The week-long hands-on summer course explored the relevant concepts and tools to understand the question of mechano sensitivity of cells.
For Training
• The objective of the course was to educate students, post docs, and faculty from engineering, biological and medical sciences about the basics of mechanics, thermodynamics, physiology, cell structure, and molecular biology in light of cell mechanosensitivity.
• The course had an hands-on component to train students on nano-fabrication, and basic cell culture. 
Capacity Building and Research
The newly expanded $18 million Illinois state funded Micro and Nanotechnology Laboratory has a mission to create, support, and sustain an environment to facilitate advanced research in photonics, microelectronics, biotechnology and nanotechnology for the benefit of the university community, the state of Illinois, and the nation.
The AFOSR grant has markedly helped in transforming the recently expanded MNTL from being compound semiconductor and micro/nano electronics facility, to also being a state-of-the-art bionanotechnology laboratory space, as envisioned prior to the recent expansion. This has not only helped MNTL in under-taking cutting-edge research, some of which is highlighted in the next section, but also being used in training the next generation workforce, addressing such issues as battlefield injuries, viruses, and cancer, by working at the confluence of biotechnology and nanotechnology, Nanomedicine, and mechanobiology.
Research and Development
The liquid-handling equipment is being used for several projects. In particular the: where a protein called Apoptosis Inducing Factor (AIF) located in cell's mitochondria can translocate into nucleus, bind to the DNA, and causes DNA fragmentation. This process occurs normally in programmed cell death, but in neuro-degenerative diseases such as Parkinson's or Huntington disease, Apoptosis occurs often in the brain that causes unnecessary cell death. Thus, the objective is to find a certain drug that can inhibit the interaction between AIF and DNA to prevent unnecessary Apoptosis. In pharmaceutical companies, millions of small molecules (drugs) are screened to find cures for various diseases. However, the methods that companies employ are time consuming and expensive. In this work, we developed a screening protocol using photonic crystal biosensor potentially for pharmaceutical high throughput screening, which can rapidly examine 200,000 small molecules for possible inhibitors. Funded by the NIH, this work is the first time that high throughput screening is performed using label free detection system on 200,000 small molecules. The research is in collaboration with Dr. Paul Hergenrother and James Heeres in the departments of biochemistry and chemistry, University of Illinois.
Funds were used to purchase components for an Enhanced Fluorescence Microscope. Using a photonic crystal structure with an optical resonance that matches the wavelength of a laser used to excite fluorescent molecules, we can excite adsorbed fluorescent-tagged biomolecules and cells to emit more light than they would on an ordinary surface. At the same time, a photonic crystal surface can also have a resonance at the wavelength of light given off by fluorescent molecules, so that emitted photons can be directed toward a microscope objective. The enhanced excitation and extraction phenomena can be used to detect fluorescent-tagged proteins and DNA with greater sensitivity than currently-used methods. However, commercially available instrumentation currently represents a significant bottleneck in maximizing the performance of photonic-crystal enhanced fluorescence. We are currently developing a fluorescence microscope-based enhanced fluorescence instrument that provides highly efficient light coupling to and extraction from a photonic crystal. CCD-based imaging enables large-area, high-resolution and high-throughput analysis. The prototype instrument also provides label-free imaging using a nearly identical beam path as that used for enhanced fluorescence. This allows complimentary images to be precisely overlaid in order to provide spatially registered images of enhanced fluorescence and surface-bound molecular density. Furthermore, additional imaging techniques available on the microscope, including brightfield and phase contrast, can also be overlaid. We anticipate these new capabilities will significantly reduce current DNA and protein microarray detection limits and will open the door to new techniques for studying cellular adhesion, motility, and membrane-bound protein expression. Funding for this project is provided by the NSF and SRU Biosystems.
The general-purpose lab instruments, including
• Eppendorf 5415D Centrifuge Asian soybean rust is a major soybean disease which can cause premature defoliation, early maturity, low seed weight, few pod and seed production. Early detection prior to visible symptoms may be critical for timing fungicide applications. In this project, we collaborate with Prof. Glen L. Hartman of the department of crop sciences at UIUC trying to detect soybean rust spores using label-free photonic crystal biosensors. The detection system enables imaging of the spores attached to the sensor surface without the use of fluorescent labels or stains. This study may represent the first use of photonic crystal biosensors for detection of rust spores and may be the first step in reaching the goal towards developing an economical and field deployable detection system. Funding for this project is provided by Soybean Disease Biotechnology Center (SDBC) and Illinois Council on Food and Agricultural Research (C-FAR). 
Sources of Funding:
National Science Foundation Grant No. 0427657, SRU Biosystems, and USAID program.
A label-free method has been developed to observe the biological activity of human breast cancer cells using photonic crystal biosensors incorporated within 96-well microplates. This method is used to study cell attachment, proliferation, and detachment induced by the exposure of cells to potential drug compounds. The biosensors and associated imaging instrument enable quantitative measurements and visualization of cell populations attached to the sensor surface with single cell resolution. Cells are not stained with proprietary reagents that typically induce the death of the cells under study. Repeated measurement of the same cells can be made without removing them from their culture environment which allows for the direct determination of proliferation and apoptosis rates. Furthermore, the assay is simpler and more rapid than alternative cell proliferation assays and can be used for high throughput screening applications. Using this method, the effect of 61 different plant extracts on breast cancer cells has been studied, in which some extracts were shown to reduce cell proliferation while some others enhanced the rate of proliferation. The results are applicable to a wide range of cell types and compound libraries and an assay for human pancreatic cancer cells is currently under development. 
Study of Cardiac Cells
The florescent optical microscope (Olympus IX 81) is being used to study cardiac cells cultured on substrates with varying stiffness. In the near future, the same microscope will be used to study adhesion between cancer cells (funded by National Science Foundation (NSF)). (PI: Taher Saif, MechSE/CCM/MNTL).
Conclusion.
The AFOSR equipment grant helped the University of Illinois Micro and Nanotechnology Laboratory to rapidly develop bionanomedical capabilities for conducting research and training pertaining to battlefield injuries, viruses, cancer, cardio-, and neural disorders. 
